← All trials
NCT03164772
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2017
- Primary completion
- Oct 1, 2020
- Completion date
- Jul 1, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 56
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Ludwig Institute for Cancer ResearchLead sponsor
- Boehringer IngelheimCollaborator
- CureVac AGCollaborator
- PharmaJet, Inc.Collaborator
- Laura & Isaac Perlmutter Cancer CenterStudy chair
- MedImmuneCollaborator
- Cancer Research InstituteCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.